Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Lexeo Therapeutics, Inc. shareholders

As of Sep 30, 2026, 149 institutions reported holding Lexeo Therapeutics, Inc. Largest: Affinity Asset Advisors, LLC, Montanova Capital, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Lexeo Therapeutics, Inc.ChangeFiled
Affinity Asset Advisors, LLC7.25M+1.44MNov 13, 2026
Montanova Capital, LLC6.38Mno changeNov 16, 2026
BlackRock5.97M+234KNov 13, 2026
Ra Capital Management, L.P.5Mno changeNov 16, 2026
Frazier Life Sciences Management, L.P.4.82Mno changeNov 16, 2026
JPMorgan4.58M+4.49MNov 12, 2026
Vestal Point Capital, LP4.32Mno changeNov 16, 2026
Citadel4.24M+338KNov 16, 2026
Vanguard4.21M−6,631Nov 16, 2026
Balyasny Asset Management L.P.3.99M+1.58MNov 16, 2026

Lexeo Therapeutics, Inc. insider trades